Melanotan II

Melanotan II is a cyclic heptapeptide analogue of α-MSH. Its ring-shaped (cyclic) structure makes the molecule stable and potent.

Mechanism of action under investigation

Unlike the more selective Melanotan I, Melanotan II binds to multiple melanocortin receptors simultaneously. It is being studied in research in relation to melanogenesis, but due to its broader receptor binding, it acts on multiple signalling pathways. This potency and breadth make it a intensively studied, yet complex, molecule.

This description relates to the mechanism of action as studied in research and does not constitute evidence of efficacy or safety in humans.

The cyclic structure distinguishes Melanotan II from the linear Melanotan I: the ring structure contributes to its stability and greater potency. Because it binds to several melanocortin receptors simultaneously, its effect in research is broader, but also more difficult to attribute to a single mechanism. For an accurate interpretation, it is important to isolate the contribution of individual receptors as much as possible in the experimental design. This complexity makes Melanotan II both an interesting and a challenging subject for study.

Melanotan II was developed on the basis of research into α-MSH and is widely used in melanocortin pharmacology, precisely because of its broad receptor activity.

• Research focus: activation of multiple melanocortin receptors.
• Research focus: melanogenesis and pigmentation (preclinical).
• Research focus: comparison with the more selective Melanotan I.

Status and context

Melanotan II is not authorised as a medicinal product and is not a cosmetic product. The scientific literature highlights a range of systemic effects associated with broad-spectrum melanocortin agonists; this emphasises that this substance belongs exclusively in a controlled research setting. It is offered here solely for laboratory and research purposes.

It is precisely this broad receptor activity that makes Melanotan II a widely used but complex subject of study in melanocortin pharmacology. Researchers often compare it with the more selective Melanotan I in order to determine which effects are associated with which receptor, a process that requires a careful, controlled experimental design. The literature therefore emphasises the importance of controlled conditions and a critical interpretation of the results. A pure starting material, documented on a batch-by-batch basis, is a prerequisite for this.

This meticulous approach is in keeping with the material’s positioning as being for research purposes only within a controlled research environment.

Melanotan II is supplied as a lyophilised powder and reconstituted in the laboratory using bacteriostatic water. The steps below describe only the laboratory procedures for research purposes.

1. 1Allow the vial and the bacteriostatic water to reach room temperature.
2. 2Wipe the rubber stoppers of both vials with an alcohol wipe.
3. 3Allow the bacteriostatic water to run slowly down the side of the vial; do not direct it straight onto the powder.
4. 4Gently swirl the vial until everything has dissolved; do not shake.
5. 5Store the solution in the fridge and label it with the date and batch number.

You can find supplies such as bacteriostatic water, insulin syringes and alcohol wipes under ‘Lab & Accessories’. This is laboratory guidance and is expressly not intended as advice on use or dosage.

A rigorous research context

Given the broad receptor binding, a controlled, standardised experimental design is particularly important. Document the method, concentration and batch number for each experiment, so that observations remain traceable.

Prepare only the quantity you need for your research and store the solution in a cool place immediately; document the method, concentration and batch number for each experiment. Work to standardised procedures and minimise variation between experiments.

Store Melanotan II in lyophilised (powder) form in a cool, dark place to ensure maximum stability.

Practical storage tips

• Powder form: freezer (-20 °C) for long-term storage; fridge (2–8 °C) for short-term storage.
• After reconstitution: store refrigerated (2–8 °C) and use within a few weeks.
• Avoid direct light, heat and repeated temperature changes.
• Write the reconstitution date and batch number on the vial.

Careful storage preserves the purity and integrity of the research material.

Stable, cool and dark storage ensures reliable, reproducible measurement results. Check the solution for clarity before use.